Navigation Links
A new vaccine for leukemia

A new vaccine has been developed by a research team from Southampton University,which works by instigating the body's immune system to fight lymphoma,a cancer of the immune cells in the blood.//The lymphoma cells are not usually identified by the body's immune system, and so can multiply diversely.

By, using the new technique, scientists are able to remove a sample of tumour cells from a patient, and isolate the genetic material which identifies the cells as foreign bodies.This material is then multiplied in the test tube and combined with part of the toxin which causes tetanus. It is then re-injected into the patient.

Head of the research team Professor Freda Stevenson said: "In theory tumour cells should be killed by the immune system because it is designated to destroy anything which is not a normal, healthy cell.However tumour cells are decieving. Though clearly labelled, they have developed ways of switching off the immune system to their presence, thwarting any possible attack.

Professor Stephenson plans to launch a 21-patient trial of the new vaccine within six months.She believes the treatment will be without side effects, and will offer the patient immunity against their cancer for life. It is hoped that the treatment can be refined and extended to other cancers of the blood - including myeloma and myeloid leukaemia.


'"/>




Page: 1

Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. New vaccine helps allergy and asthma patients
5. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
6. HIV did not arise from polio vaccine
7. Double impact vaccine
8. High Demand for a child vaccine
9. Shortage of MMR vaccine
10. Anthrax vaccine produced
11. Problematic Use of smallpox vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... March 23, 2017 , ... Ogden Clinic, the largest ... centric payment system, to expand its focus on patient care by providing an ... , “At Ogden Clinic, we are working to become a different type ...
(Date:3/23/2017)... ... 23, 2017 , ... “The Trainer”: an electrifying and suspenseful gunslinger novel ... writer with an active imagination and an enthusiasm for action and adventure stories. ... Wild Bill Hart, who sat looking at the thirty-three notches that lined the edges ...
(Date:3/23/2017)... ... March 23, 2017 , ... Vortex Biosciences, provider of circulating ... in circulating tumor cells using microfluidic western blotting” in Nature Communications on March ... technology to capture CTCs and a microfluidic single-CTC resolution Western blot from ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... publication of the first issue of its companion print magazine. The new magazine, ... cosmetic surgery thanks to information provided by board-certified doctors from across the country. ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... California Bay Area providing insurance assistance, financial planning, and related services to residents ... Species International to promote awareness of threatened species and wild lands. , Endangered ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... March 23, 2017 On ... the trading session at 5,821.64, up 0.48%; the ... finish at 20,661.30; and the S&P 500 closed ... based as six out of nine sectors ended ... initiated reports coverage on the following Medical Instruments ...
(Date:3/23/2017)... , March 23, 2017 BioLineRx Ltd. ... immunology, announced today that it has acquired Agalimmune Ltd., a ... consideration consisted of a $6 million upfront payment, of which ... shares. Additional future payments may be made based on development ... ...
(Date:3/23/2017)... AVIV, Israel, March 23, 2017  Galmed Pharmaceuticals ... the "Company"), a clinical-stage biopharmaceutical company focused on ... the treatment of nonalcoholic steatohepatitis, or NASH, and ... the three and twelve months ended December 31, 2016, ... completed pre-clinical studies demonstrating Aramchol™,s potential direct effect ...
Breaking Medicine Technology: